Microfluidic Chips for In Situ Crystal X-ray Diffraction and In Situ Dynamic Light Scattering for Serial Crystallography
April 24th, 2018
16.1K views
This protocol describes in detail how to fabricate and operate microfluidic devices for X-ray diffraction data collection at room temperature. Additionally, it describes how to monitor protein crystallization by dynamic light scattering and how to process and analyze obtained diffraction data.
Overview
This protocol outlines the fabrication and operation of microfluidic devices for X-ray diffraction data collection at room temperature. It also details the monitoring of protein crystallization using dynamic light scattering and the subsequent processing and analysis of the diffraction data.
Key Study Components
Area of Science
- Microfluidics
- Protein Crystallization
- X-ray Diffraction
Background
- Microfluidic devices minimize mechanical disturbance to protein crystals.
- X-ray transparent chips can be easily produced and mounted on synchrotron beamlines.
- Efficient use of available crystals enhances data collection.
- Dynamic light scattering is used to monitor crystallization processes.
Purpose of Study
- To fabricate a microfluidic device for protein crystallization.
- To collect X-ray diffraction data at room temperature.
- To analyze the diffraction data for structural insights.
Methods Used
- Fabrication of PDMS and epoxy molds for microfluidic devices.
- Silanization of polyimide foils to enhance bonding.
- Injection of crystallization solutions into the microfluidic chip.
- Monitoring crystallization under a microscope.
Main Results
- Successful fabrication of microfluidic devices for protein crystallization.
- Effective monitoring of crystallization using dynamic light scattering.
- Collection of high-quality X-ray diffraction data.
- Demonstration of minimized mechanical disturbance to crystals.
Conclusions
- Microfluidic devices are advantageous for protein crystallization studies.
- The protocol provides a reliable method for X-ray diffraction data collection.
- Dynamic light scattering is a valuable tool for monitoring crystallization.
Frequently Asked Questions
What are the advantages of using microfluidic devices for crystallization?
Microfluidic devices minimize mechanical disturbance to protein crystals and allow for efficient use of available crystals during X-ray data collection.
How is dynamic light scattering used in this protocol?
Dynamic light scattering is employed to monitor the protein crystallization process within the microfluidic devices.
What temperature is used for X-ray diffraction data collection?
The X-ray diffraction data collection is performed at room temperature.
What materials are used in the fabrication of the microfluidic devices?
The devices are primarily fabricated using PDMS and epoxy resin.
How does the protocol ensure the quality of the X-ray diffraction data?
The protocol includes steps to minimize air bubbles and mechanical disturbances, ensuring high-quality data collection.
Executive Industry Relevance
This microfluidic approach enables room-temperature serial crystallography with minimal mechanical disturbance to fragile protein crystals, supporting early-stage target validation by preserving native conformational states. By integrating in situ dynamic light scattering for nucleation monitoring and goniometer-based fixed-target data collection, the method improves predictive confidence in structural assays and reduces attrition due to crystal damage. The low-X-ray-background design and compatibility with standard synchrotron beamlines enhance throughput and reproducibility in fragment screening and lead optimization campaigns.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables structural interrogation of therapeutic targets using native-state crystals grown and interrogated in situ, reducing artefacts from cryo-preservation or manual handling.
- Operational Value: Supports high-efficiency crystal utilization, where nearly every grown crystal contributes to diffraction data, improving assay yield and reducing reagent consumption.
Screening & Assay Development
- Scientific Value: Facilitates assay standardization through capillary-valved nanoliter droplet formation, ensuring consistent sample volumes for reproducible nucleation and growth screening.
- Operational Value: Eliminates need for pumps or specialized fluidic actuation, enabling manual, low-cost setup in non-cleanroom environments for scalable assay deployment.
Translational & Preclinical Research
- Scientific Value: Provides a disease-relevant system for monitoring protein-protein interactions or ligand-induced conformational changes via in situ DLS and diffraction, supporting mechanistic de-risking.
- Operational Value: Enables seamless transition from crystallization to data collection on the same chip, minimizing sample transfer steps and preserving target integrity for downstream preclinical evaluation.
Pipeline & Workflow Integration
The method integrates into the discovery workflow from hit confirmation through lead identification, where structural data from room-temperature crystallography informs SAR and binding mode analysis.
- Discovery Biology: Supports hypothesis testing by enabling rapid structural validation of hits or fragments using crystals grown under near-physiological conditions.
- Screening: Delivers assay readiness through standardized, reproducible nanoliter compartmentalization and in situ monitoring via DLS, ensuring only well-formed crystals proceed to diffraction.
- Analytics: Generates quantitative diffraction intensity decay metrics and R-factor trends over time, allowing teams to assess radiation damage and data quality across serial datasets.
- Translational Research: Connects to preclinical continuity by providing structural insights into target flexibility and ligand binding, informing affinity maturation and specificity optimization.
- Enterprise Reuse: Represents a reusable platform capability, as chip design can be adapted to varying compartment sizes or counts without reformulating core fabrication steps.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by minimizing crystal perturbation and radiation-induced artefacts, improving confidence in target-ligand structural interpretations.
- Operational Value: Enhances standardization and reproducibility through batch fabrication from a single PDMS master, with all steps performable outside cleanrooms in ~3 hours.
- Strategic Value: Improves go/no-go decisions by enabling rapid, damage-aware structural characterization, reducing late-stage biological risk in lead optimization.
- Portfolio Impact: Supports risk-adjusted prioritization through reliable structural readouts that inform compound advancement or termination based on target engagement evidence.
Implementation Considerations
- Requires expertise in microfluidic design, protein crystallization, and synchrotron-based X-ray data collection.
- Depends on access to goniometer-equipped beamlines and software tools for processing serial crystallography datasets (e.g., CrystFEL, phenix.refine).
- Necessitates cross-team standardization between structural biology, microfluidics, and data analysis units for consistent chip preparation and diffraction monitoring.
- Adaptation across model systems may require adjustments to surface chemistry or channel dimensions to accommodate varying protein viscosities or crystallization kinetics.
- Practical limitations include radiation damage accumulation in high-density crystal arrays and the need for careful compartment isolation to prevent cross-talk during data collection.
Biopharma FAQs
Why does monitoring nucleation via dynamic light scattering improve target validation?
Dynamic light scattering enables real-time detection of protein crystal nucleation within microfluidic chambers, allowing researchers to optimize precipitant concentrations and timing before diffraction data collection. This control ensures that only well-formed, monodisperse crystals are selected for X-ray exposure, reducing structural ambiguity from mixed-phase or amorphous aggregates. By linking nucleation control to data quality, the method increases confidence in interpreting ligand-bound states during early target validation.
How does isolating independent variables in microfluidic compartments support the discovery pipeline?
The chip design uses capillary valving to split reaction mixtures into defined nanoliter droplets, isolating each crystallization condition as an independent variable. This prevents cross-contamination and enables parallel screening of multiple precipitant or ligand concentrations under identical environmental controls. Such isolation supports reproducible hit confirmation and lead refinement by ensuring that observed differences in crystal quality or diffraction stem from intentional variable changes, not technical noise.
What quantitative dependent variable measurements enable data-driven go/no-go decisions?
The protocol measures normalized diffraction power over time and calculates R-factor values from serial datasets to quantify radiation damage and data integrity. A drop in diffraction power below 50% and rising R-factor indicate degradation, informing whether a crystal batch is suitable for high-resolution structure solution. These quantitative readouts allow teams to set thresholds for data usability, directly influencing decisions on whether to advance a target-ligand pair based on structural confidence.
Why do replication requirements matter for cross-functional collaboration in serial crystallography?
Replicating diffraction datasets across multiple crystals and frames (e.g., 10 patterns per crystal from 83 crystals) ensures that observed structural features are consistent and not artefacts of individual crystal variability or radiation damage. This replication supports reliable data merging and refinement, which is essential when structural biologists, medicinal chemists, and modeling teams depend on consistent electron density maps for interpretation. Standardized replication criteria reduce variability in shared datasets, improving trust and alignment across discovery teams.
What statistical analysis capabilities are required before implementing this microfluidic serial crystallography approach?
Implementation requires the ability to split diffraction datasets into sub-datasets by frame, calculate normalized diffraction power over time, and evaluate R-factor trends to assess radiation damage. Teams must also be capable of merging partial datasets and refining structures using tools like phenix.refine or REMAC to derive meaningful structural insights. These statistical and analytical capabilities are necessary to distinguish true ligand-induced conformational changes from data degradation artefacts before drawing conclusions for target validation.
Chapters in this video
0:04
Title
0:38
Polydimethylsiloxane (PDMS) Mold Fabrication and In Situ X-ray Chip Fabrication
4:59
Fluid Delivery Access Ports and Surface Treatment
6:51
Protein Preparation and Crystallization
8:51
Results: Crystallization and In Situ X-ray Diffraction of Protein Crystals
10:41
Conclusion
